Search for: "State v. Bristol-Myers Squibb Company "
Results 121 - 140
of 159
Sorted by Relevance
|
Sort by Date
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
15 Oct 2012, 1:24 am
It is not even the largest securities suit settlement, having been exceeded, among others, by Bristol Myers Squibb’s $300 million securities lawsuit settlement (about which refer here). [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
20 Jan 2016, 5:21 am
Joe Company, Wm. [read post]
16 Jun 2014, 4:45 am
See Bristol-Myers Squibb Co. v. [read post]
11 Jan 2017, 7:19 am
United States 16-309 Issue: Whether the U.S. [read post]
5 Nov 2007, 12:58 pm
Bristol-Myers Squibb, 97 F. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
26 Mar 2011, 5:00 pm
Bristol-Myers Squibb Co. v. [read post]
20 May 2012, 1:11 pm
The number 50 million: The number of people in the US since 1997, that have taken Bristol-Myers Squibb's blood-thinning drug Plavix. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
27 Feb 2009, 7:00 am
(Techdirt) How companies can cash in on innovations and patents (IP Frontline) International Property Rights Index 2009 - New report identifies world’s most IP-friendly country, but trade marks are ignored (IAM) What do clients want? [read post]
25 Apr 2015, 11:03 am
Third, the Manual authors state that the doubling argument assumes the “[n]onacceleration of disease. [read post]
7 Jan 2014, 9:22 am
Bristol Myers Squibb and other companies were inundated by silicone breast implant cases, and plaintiffs had managed to snucker a few juries into returning large verdicts against the defendants. [read post]
12 Jan 2017, 7:01 am
United States, 16-309). [read post]
18 Aug 2022, 12:26 pm
Johnson v. [read post]
2 Jan 2014, 8:08 am
Bristol Myers Squibb and other companies were inundated by silicone breast implant cases, and plaintiffs had managed to snucker a few juries into returning large verdicts against the defendants. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
